PTPRC and neoplasm: Tumors were harvested 20 days post tumor inoculation and analyzed by comparing the percentage of CD8+ and CD4+ cells in the CD45+ cell population (Figure 7a,b), as well as the percentage of Treg+ cells in the CD45+/CD4+/foxP3+ cell population (Figure 7c).